Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Thorax|July 25, 2015
Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)Liam G Heaney, Ratko Djukanovic, Ashley Woodcock, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2020
Characterization of the Inflammatory Response to Severe COVID-19 IllnessOliver J McElvaney, Natalie L McEvoy, Oisín F McElvaney, et al.
Thorax|January 14, 2017
Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activityGabriele Spina, Martijn A Spruit, Jennifer Alison, et al.
Chest|May 21, 2025
Prediction pathway for severe asthma exacerbations: a Bayesian Network analysisChandra Prakash Yadav, Atlanta Chakraborty, David B Price, et al.
Chest|April 22, 2021
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma CohortLiam G Heaney, Luis Perez de Llano, Mona Al-Ahmad, et al.
BMC Medical Research Methodology|August 22, 2020
International severe asthma registry (ISAR): protocol for a global registryJ Mark FitzGerald, Trung N Tran, Marianna Alacqua, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Pageof 27